FDA Drug Application (022121) for TIROSINT by INST BIOCHIMIQUE

Back to FDA Applications sponsored by INST BIOCHIMIQUE

Application Number022121
Product Number001
FormCAPSULE;ORAL
Dosage0.013MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTIROSINT
Active IngredientLEVOTHYROXINE SODIUM

Active IngredientCount
List of drugs with Active Ingredient LEVOTHYROXINE SODIUM9


Back to FDA Applications sponsored by INST BIOCHIMIQUE